Polymer Capital Management (Us) LLC Arvinas, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $846 Billion
- Q2 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 54,617 shares of ARVN stock, worth $528,692. This represents 0.05% of its overall portfolio holdings.
Number of Shares
54,617
Previous 16,842
224.29%
Holding current value
$528,692
Previous $118 Million
240.0%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
68.3MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$90.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$60.6 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$35.6 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$31.9 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$20.8 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $515M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...